BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34194582)

  • 21. Double minute chromosomes in a patient with myelodysplastic syndrome transforming into acute myeloid leukemia.
    Michalová K; Cermák J; Brezinová J; Zemanová Z
    Cancer Genet Cytogenet; 1999 Feb; 109(1):76-8. PubMed ID: 9973965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic, immunophenotypic, and NPM1/FLT3 mutational studies on 17 patients with normal karyotype acute myeloid leukemia (AML) followed by aberrant karyotype AML at relapse.
    Wang ES; Sait SN; Gold D; Mashtare T; Starostik P; Ford LA; Wetzler M; Nowak NJ; Deeb G
    Cancer Genet Cytogenet; 2010 Oct; 202(2):101-7. PubMed ID: 20875872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of amplified DNA sequences on double minute chromosomes in a leukemic cell line KY821 by means of spectral karyotyping and comparative genomic hybridization.
    Ariyama Y; Sakabe T; Shinomiya T; Mori T; Fukuda Y; Inazawa J
    J Hum Genet; 1998; 43(3):187-90. PubMed ID: 9747033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MYC amplification in two further cases of acute myeloid leukemia with trisomy 4 and double minute chromosomes.
    O'Malley F; Rayeroux K; Cole-Sinclair M; Tong M; Campbell LJ
    Cancer Genet Cytogenet; 1999 Mar; 109(2):123-5. PubMed ID: 10087944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double minute chromosomes in monoblastic (M5) and myeloblastic (M2) acute myeloid leukemia: two case reports and a review of literature.
    Thomas L; Stamberg J; Gojo I; Ning Y; Rapoport AP
    Am J Hematol; 2004 Sep; 77(1):55-61. PubMed ID: 15307107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a secondary FLT3/A848P mutation in a patient with FLT3-ITD-positive blast phase CMML and response to sunitinib and sorafenib.
    von Bubnoff N; Rummelt C; Menzel H; Sigl M; Peschel C; Duyster J
    Leukemia; 2010 Aug; 24(8):1523-5. PubMed ID: 20520641
    [No Abstract]   [Full Text] [Related]  

  • 27. A constitutively active SPTBN1-FLT3 fusion in atypical chronic myeloid leukemia is sensitive to tyrosine kinase inhibitors and immunotherapy.
    Grand FH; Iqbal S; Zhang L; Russell NH; Chase A; Cross NC
    Exp Hematol; 2007 Nov; 35(11):1723-7. PubMed ID: 17764812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amplification on double-minute chromosomes and partial-tandem duplication of the MLL gene in leukemic cells of a patient with acute myelogenous leukemia.
    Ariyama Y; Fukuda Y; Okuno Y; Seto M; Date K; Abe T; Nakamura Y; Inazawa J
    Genes Chromosomes Cancer; 1998 Nov; 23(3):267-72. PubMed ID: 9790509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double minute chromosomes contain amplified c-myc oncogene sequences in acute myeloid leukemia.
    Mohamed AN; Mahalak S; Goldfarb SB; Palutke M
    Hematopathol Mol Hematol; 1996; 10(4):193-9. PubMed ID: 9042662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double minutes and c-MYC amplification in acute myelogenous leukemia: Are they prognostic factors?
    Bruckert P; Kappler R; Scherthan H; Link H; Hagmann F; Zankl H
    Cancer Genet Cytogenet; 2000 Jul; 120(1):73-9. PubMed ID: 10913679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3q26/EVI1 rearrangement in myelodysplastic/myeloproliferative neoplasms: An early event associated with a poor prognosis.
    Hu Z; Hu S; Ji C; Tang Z; Thakral B; Loghavi S; Medeiros LJ; Wang W
    Leuk Res; 2018 Feb; 65():25-28. PubMed ID: 29288910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MYC gene amplification in double minute chromosomes in an aggressive large B-cell lymphoma with leukemic presentation: a case report.
    Alseraye F; Padmore R; Wozniak M; McGowan-Jordan J
    Cancer Genet Cytogenet; 2009 Jul; 192(2):76-8. PubMed ID: 19596258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extrachromosomal gene amplification in acute myeloid leukemia; characterization by metaphase analysis, comparative genomic hybridization, and semi-quantitative PCR.
    Mohamed AN; Macoska JA; Kallioniemi A; Kallioniemi OP; Waldman F; Ratanatharathorn V; Wolman SR
    Genes Chromosomes Cancer; 1993 Nov; 8(3):185-9. PubMed ID: 7509627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Localization of amplified MYC gene sequences to double minute chromosomes in acute myelogenous leukemia.
    Slovak ML; Ho JP; Pettenati MJ; Khan A; Douer D; Lal S; Traweek ST
    Genes Chromosomes Cancer; 1994 Jan; 9(1):62-7. PubMed ID: 7507702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RUNX1 deletion/amplification in therapy-related acute myeloid leukemia: A case report and review of the literature.
    Nguyen D; Li Y; Safah H; Brown TC
    Cancer Genet; 2019 Oct; 238():37-43. PubMed ID: 31425924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amplification of the AML1(CBFA2) gene on ring chromosomes in a patient with acute myeloid leukemia and a constitutional ring chromosome 21.
    Streubel B; Valent P; Lechner K; Fonatsch C
    Cancer Genet Cytogenet; 2001 Jan; 124(1):42-6. PubMed ID: 11165321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic myelomonocytic leukemia with ETV6-ABL1 rearrangement and SMC1A mutation.
    Cessna MH; Paulraj P; Hilton B; Sadre-Bazzaz K; Szankasi P; Cluff A; Patel JL; Hoda D; Toydemir RM
    Cancer Genet; 2019 Oct; 238():31-36. PubMed ID: 31425923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trisomy 6 and double minute chromosomes in a case of chronic myelomonocytic leukemia.
    Sambani C; Trafalis DT; Vessalas G; Politis G; Peristeris P; Nakopoulou L; Giannopoulou J; Michaelidis C; Ayoutantis M; Pantelias GE
    Cancer Genet Cytogenet; 1998 Oct; 106(2):180-1. PubMed ID: 9797788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic myelomonocytic leukemia evolving from preexisting myelodysplasia shares many features with de novo disease.
    Wang SA; Galili N; Cerny J; Sechman E; Chen SS; Loew J; Liu Q; Fadare O; Hasserjian R; Jones D; Qawi H; Woda B; Raza A
    Am J Clin Pathol; 2006 Nov; 126(5):789-97. PubMed ID: 17050076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activating FLT3 mutations are rare in children with juvenile myelomonocytic leukemia.
    Gratias EJ; Liu YL; Meleth S; Castleberry RP; Emanuel PD
    Pediatr Blood Cancer; 2005 Feb; 44(2):142-6. PubMed ID: 15390271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.